GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skin Elements Ltd (ASX:SKN) » Definitions » Valuation Rank

Skin Elements (ASX:SKN) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is Skin Elements Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Skin Elements Valuation Rank Related Terms

Thank you for viewing the detailed overview of Skin Elements's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Skin Elements Business Description

Traded in Other Exchanges
N/A
Address
1242 Hay Street, West Perth, Perth, WA, AUS, 6005
Skin Elements Ltd is a company that operates in the beauty and personal care industry. The principal business activities include the manufacture and distribution of natural, organic, health, and wellness products. Its brand portfolio includes Soleo Organics natural sunscreen brand, the PapayaActivs therapeutic skincare range, Elizabeth Jane Natural Cosmetics, and the recently developed Invisi-Shield SuprCuvr plant-based hospital-grade disinfectant range. The company has a single segment being research and development of the inventive proprietary SE Formula biotechnology.